<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454711</url>
  </required_header>
  <id_info>
    <org_study_id>35RC17_8949_AddictO</org_study_id>
    <secondary_id>2017-A01269-44</secondary_id>
    <nct_id>NCT03454711</nct_id>
  </id_info>
  <brief_title>Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway</brief_title>
  <acronym>AddictO</acronym>
  <official_title>Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut NuMeCan, INRA 1341</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identification of the cerebral fMRI phenotype of obese patients with FA in cognitive task
      context based on food choice making
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is a worldwide epidemic associated with many complications. The treatment of obesity
      is a failure if it does not take into account eating disorders. Among them, food addictions
      seem to be frequent among obese patients. Clinical diagnosis and therapeutic approaches
      depend on presence of these FA. Moreover, eating disorders are associated with visible brain
      abnormalities in fMRI but the cerebral fMRI phenotype of FA is not known.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant change in brain activity of the prefrontal cortex (area involved in the inhibitory control of food intake) measured by modification of BOLD (Blood-Oxygen-Level-Dependent) signal in fMRI during a cognitive task based on food choice making</measure>
    <time_frame>Month 2</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire.
Three clinical visits will be realized in less than two months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without food addictions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients (20) will be selected from the Yale Food Addiction Scale (YFAS): a validated screening of FA questionnaire.
Three clinical visits will be realized in less than two months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Brain MRI</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indirect calorimetry</intervention_name>
    <description>Resting energy expenditure</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioimpedance</intervention_name>
    <description>Measurement of body composition</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lipid profile, glucose, HBA1c, metabolomic analysis</intervention_name>
    <description>Blood sample</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>YFAS questionnaire, Binge Eating Scale, Hospital Anxiety and Depression (HAD) scale, hedonic evaluation test (liking)</intervention_name>
    <description>Questionnaires to characterize eating habits and depression</description>
    <arm_group_label>Patient with food addcitions</arm_group_label>
    <arm_group_label>Patients without food addictions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female

          -  right-handed

          -  grade 1 and 2 obesity

          -  aged between 30 and 50

          -  no other addictions including smoking

          -  no contraindications to fMRI

          -  affiliated to French Social Security

          -  having given a written informed consent

        Exclusion Criteria:

          -  abdominal circumference + upper limbs along the body &gt; 200cm

          -  addiction to alcohol or other psychoactive substances

          -  daily smoker

          -  sleep Apnea Syndrome paired

          -  psychotic psychiatric disorders

          -  history of bariatric surgery

          -  medical care in the nutrition unit

          -  inability to comprehend or complete questionnaires

          -  pregnant or breastfeeding woman

          -  persons subject to major legal protection (safeguarding justice, guardianship,
             trusteeship), persons deprived of liberty.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Val-Laillet, MSc, PhD, HDR</last_name>
    <role>Study Director</role>
    <affiliation>Institut NuMeCan, INRA 1341, INSERM 1241, Université de Rennes 1</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ronan Thibault, MD, PhD</last_name>
    <phone>+33 2 99 28 96 46</phone>
    <email>ronan.thibault@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mickaël Som, MD</last_name>
    <phone>06 67 68 86 71</phone>
    <email>mickael.som@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronan Thibault, MD, PhD</last_name>
      <phone>+33 2 99 28 96 46</phone>
      <email>ronan.thibault@chu-rennes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Mickaël Som, MD</last_name>
      <phone>06 67 68 86 71</phone>
      <email>mickael.som@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Food addictions</keyword>
  <keyword>Functional magnetic resonance imaging (fMRI)</keyword>
  <keyword>Metabolomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

